Addition of ADAMTS13 testing to cryptogenic stroke evaluation: index case and single-center screening initial experience
Blood Adv
.
2025 Dec 9;9(23):6120-6123.
doi: 10.1182/bloodadvances.2025017702.
Authors
Aaron Boothby
1
,
Jorge N Ruiz Lopez
1
,
Livia Hegerova
1
,
Dharmini Manogna
2
,
Rangaswamy Chintapatla
3
,
Samantha Harris
4
,
Gayle Teramura
4
,
David Tirschwell
5
,
Breana Taylor
5
,
Siobán Keel
1
Affiliations
1
Division of Hematology and Oncology, University of Washington, Seattle, WA.
2
Providence Medical Oncology & Hematology, Spokane, WA.
3
Hematology & Oncology, Kadlec Clinic, Kennewick, WA.
4
Bloodworks Northwest, Seattle, WA.
5
Department of Neurology, University of Washington, Seattle, WA.
PMID:
40875889
PMCID:
PMC12719145
DOI:
10.1182/bloodadvances.2025017702
No abstract available